Scarica l'app Stockscreener
4.96
0.03%
0.010
Precedente Chiudi:
$4.95
Aprire:
$4.95
Volume 24 ore:
354.93K
Relative Volume:
0.50
Capitalizzazione di mercato:
$297.81M
Reddito:
-
Utile/perdita netta:
$-44.80M
Rapporto P/E:
-6.6133
EPS:
-0.75
Flusso di cassa netto:
$-30.67M
1 W Prestazione:
-5.33%
1M Prestazione:
-5.87%
6M Prestazione:
+129.23%
1 anno Prestazione:
+5.35%
Intervallo 1D:
$4.795
$4.99
Intervallo di 1 settimana:
$4.795
$5.35
Portata 52W:
$1.14
$7.20
Aldeyra Therapeutics Inc Stock (ALDX) Company Profile
Nome
Aldeyra Therapeutics Inc
Settore
Industria
Telefono
781-761-4904
Indirizzo
131 HARTWELL AVENUE, LEXINGTON, MA
Confronta ALDX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ALDX
Aldeyra Therapeutics Inc
|
4.97 | 297.81M | 0 | -44.80M | -30.67M | -0.75 |
|
ARGX
Argen X Se Adr
|
922.95 | 57.24B | 3.06B | 1.28B | 447.35M | 19.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
435.89 | 110.12B | 11.74B | 3.68B | 3.34B | 14.19 |
|
INSM
Insmed Inc
|
200.75 | 42.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
|
ONC
Beone Medicines Ltd Adr
|
364.81 | 41.68B | 4.98B | 69.59M | 525.67M | 0.5197 |
|
REGN
Regeneron Pharmaceuticals Inc
|
724.33 | 74.02B | 14.25B | 4.58B | 3.88B | 41.77 |
Aldeyra Therapeutics Inc Stock (ALDX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-04-03 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2024-04-02 | Ripresa | H.C. Wainwright | Buy |
| 2022-04-27 | Ripresa | H.C. Wainwright | Buy |
| 2021-02-08 | Iniziato | H.C. Wainwright | Buy |
| 2020-12-16 | Iniziato | Berenberg | Buy |
| 2020-10-30 | Iniziato | Jefferies | Buy |
| 2020-10-16 | Iniziato | BTIG Research | Buy |
| 2020-09-22 | Iniziato | Alliance Global Partners | Buy |
| 2020-05-12 | Iniziato | Oppenheimer | Outperform |
| 2018-12-04 | Iniziato | Citigroup | Buy |
| 2018-09-26 | Reiterato | Cantor Fitzgerald | Overweight |
| 2018-09-13 | Iniziato | Janney | Buy |
| 2018-01-26 | Iniziato | Seaport Global Securities | Buy |
| 2016-09-26 | Iniziato | H.C. Wainwright | Buy |
| 2016-07-01 | Iniziato | Stifel | Buy |
| 2015-07-01 | Iniziato | Canaccord Genuity | Buy |
| 2015-03-25 | Iniziato | Chardan Capital Markets | Buy |
| 2015-03-20 | Reiterato | H.C. Wainwright | Buy |
| 2014-11-18 | Iniziato | H.C. Wainwright | Buy |
| 2014-06-19 | Iniziato | Aegis Capital | Buy |
Mostra tutto
Aldeyra Therapeutics Inc Borsa (ALDX) Ultime notizie
Live market analysis of Aldeyra Therapeutics Inc.Treasury Yields & Fast Gaining Stock Reports - newser.com
Aldeyra Therapeutics Inc. stock daily chart insightsFed Meeting & Safe Capital Growth Stock Tips - newser.com
Why Aldeyra Therapeutics Inc. stock is in analyst buy zone2025 Price Action Summary & Low Drawdown Trading Strategies - newser.com
Sentiment analysis tools applied to Aldeyra Therapeutics Inc.July 2025 Recap & Weekly Market Pulse Alerts - newser.com
Smart tools for monitoring Aldeyra Therapeutics Inc.’s price actionWeekly Trading Summary & AI Forecast Swing Trade Picks - newser.com
Applying Wyckoff theory to Aldeyra Therapeutics Inc. stock2025 AllTime Highs & Growth Focused Entry Reports - newser.com
Aldeyra Therapeutics Inc.’s volatility index tracking explainedJuly 2025 Closing Moves & Low Risk Investment Opportunities - newser.com
What to expect from Aldeyra Therapeutics Inc. in the next 30 daysTrade Ideas & Weekly Top Gainers Trade List - newser.com
How Aldeyra Therapeutics Inc. stock performs in weak economyMarket Trend Summary & Entry Point Confirmation Alerts - newser.com
Intraday pattern recognizer results for Aldeyra Therapeutics Inc.2025 Price Targets & Smart Money Movement Alerts - newser.com
Can a trend reversal in Aldeyra Therapeutics Inc. lead to recoveryLayoff News & Stock Timing and Entry Methods - newser.com
Is Aldeyra Therapeutics Inc. stock resilient to inflation2025 Market Sentiment & Accurate Intraday Trade Tips - Fundação Cultural do Pará
Is Aldeyra Therapeutics Inc. stock dividend yield sustainableQuarterly Market Summary & Pattern Based Trade Signal System - Fundação Cultural do Pará
Aldeyra Therapeutics Announces Expansion of RASP Platform to Include Central Nervous System Diseases and Provides Updates on Reproxalap at Research and Development Webcast - MarketScreener
Is Aldeyra Therapeutics Inc. stock affected by interest rate hikesPortfolio Update Report & Free Expert Verified Stock Movement Alerts - newser.com
Aldeyra expands RASP platform to include neuroinflammatory diseases By Investing.com - Investing.com Nigeria
Understanding Aldeyra Therapeutics Inc.’s price movementQuarterly Performance Summary & Consistent Return Investment Signals - newser.com
Automated trading signals detected on Aldeyra Therapeutics Inc.Dip Buying & Stepwise Trade Execution Plans - newser.com
Analyzing net buyer seller activity in Aldeyra Therapeutics Inc.Risk Management & Real-Time Buy Signal Alerts - newser.com
ALDX: ADX-248 advances in CNS and immune diseases as reproxalap nears FDA approval, with strong financials - TradingView
Published on: 2025-11-13 12:25:09 - newser.com
Aldeyra (ALDX) Expands RASP Platform to Target Neuroinflammatory Diseases - GuruFocus
Aldeyra Therapeutics announces expansion of rasp platform - MarketScreener
Aldeyra expands RASP platform to include neuroinflammatory diseases - Investing.com India
Aldeyra Therapeutics Expands RASP Platform and Updates on Reproxalap - TradingView
Key FDA Verdict Looms for Aldeyra’s Lead Drug Candidate - AD HOC NEWS
Aldeyra (NASDAQ: ALDX) reports FDA inspections of reproxalap facilities closed with VAI - Stock Titan
Aldeyra Therapeutics Inc Azioni (ALDX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Aldeyra Therapeutics Inc Azioni (ALDX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Machatha Stephen | Chief Development Officer |
Aug 11 '25 |
Sale |
5.15 |
22,073 |
113,713 |
221,799 |
0.01%
0.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):